Hosted on MSN1mon
Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows
Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe ... at the Dana-Farber Cancer Institute in Boston, said in the news release. Dr. Douglas Marks ...
CNN6y
Merck & Co., Inc.
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care ...